Literature DB >> 20724155

Prenylflavonoids from Glycyrrhiza uralensis and their protein tyrosine phosphatase-1B inhibitory activities.

Songpei Li1, Wei Li, Yinghua Wang, Yoshihisa Asada, Kazuo Koike.   

Abstract

Two new 2-arylbenzofurans, glycybenzofuran (1) and cyclolicocoumarone (2), together with 10 known flavonoids including licocoumarone (3), glycyrrhisoflavone (4), glisoflavone (5), cycloglycyrrhisoflavone (6), isoliquiritigenin (7), licoflavone A (8), apigenin (9), isokaempferide (10), glycycoumarin (11), and isoglycycoumarin (12), were isolated from the roots of Glycyrrhiza uralensis and their structures were determined by extensive spectroscopic analyses. Compounds 1 and 5 showed significant protein tyrosine phosphatase-1B (PTP1B) inhibitory activity in vitro with the IC50 values of 25.5 and 27.9 microM, respectively. The structure-activity relationship indicated that the presence of prenyl group and ortho-hydroxy group is important for exhibiting the activity. Kinetic analysis indicated that compound 1 inhibits PTP1B by a competitive mode, whereas compound 5 by a mixed mode. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724155     DOI: 10.1016/j.bmcl.2010.07.110

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Protein tyrosine phosphatase 1B inhibitory activities of ursane- and lupane-type triterpenes from Sorbus pohuashanensis.

Authors:  Dongxia Li; Wei Li; Koji Higai; Kazuo Koike
Journal:  J Nat Med       Date:  2013-10-06       Impact factor: 2.343

2.  Isolation, structural elucidation and in vitro hepatoprotective activity of flavonoids from Glycyrrhiza uralensis.

Authors:  Ming Cheng; Liqin Ding; Hongfeng Kan; Hongmin Zhang; Benke Jiang; Yingjie Sun; Shijie Cao; Wei Li; Kazuo Koike; Feng Qiu
Journal:  J Nat Med       Date:  2019-06-19       Impact factor: 2.343

Review 3.  Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades.

Authors:  Cheng-Shi Jiang; Lin-fu Liang; Yue-wei Guo
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

4.  Rapid regio- and multi-coupling reactivity of 2,3-dibromobenzofurans with atom-economic triarylbismuths under palladium catalysis.

Authors:  Maddali L N Rao; Jalindar B Talode; Venneti N Murty
Journal:  Beilstein J Org Chem       Date:  2016-09-22       Impact factor: 2.883

5.  Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.

Authors:  Anna Vuorinen; Roger T Engeli; Susanne Leugger; Fabio Bachmann; Muhammad Akram; Atanas G Atanasov; Birgit Waltenberger; Veronika Temml; Hermann Stuppner; Liselotte Krenn; Sylvin B Ateba; Dieudonné Njamen; Rohan A Davis; Alex Odermatt; Daniela Schuster
Journal:  J Nat Prod       Date:  2017-03-20       Impact factor: 4.050

Review 6.  Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids.

Authors:  Yufan Wu; Zhuxian Wang; Qunqun Du; Zhaoming Zhu; Tingting Chen; Yaqi Xue; Yuan Wang; Quanfu Zeng; Chunyan Shen; Cuiping Jiang; Li Liu; Hongxia Zhu; Qiang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-17       Impact factor: 2.629

7.  Licoflavone A Suppresses Gastric Cancer Growth and Metastasis by Blocking the VEGFR-2 Signaling Pathway.

Authors:  Gong Hongxia; Jin Xiaojie; Leng Guangxian; Zhang Min; Niu Shiwei; Cao Wangjie; Zhang Han; Zeng Yuanding; Li Chenghao; Li Yaling; Su Yun; Liu Yongqi
Journal:  J Oncol       Date:  2022-04-25       Impact factor: 4.501

Review 8.  Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives.

Authors:  Qiang Zhang; Yu-Hang Miao; Teng Liu; Yin-Ling Yun; Xiao-Ya Sun; Tao Yang; Jie Sun
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

9.  Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents.

Authors:  Toshihisa Onoda; Wei Li; Koji Higai; Kazuo Koike
Journal:  BMC Complement Altern Med       Date:  2014-02-20       Impact factor: 3.659

Review 10.  Osteoarthritis Is a Low-Grade Inflammatory Disease: Obesity's Involvement and Herbal Treatment.

Authors:  Mustapha Zeddou
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.